CHICAGO, Sept. 7, 2021 /PRNewswire/ — GTCR, a number one personal fairness agency, introduced immediately that its Antylia Scientific portfolio firm (“Antylia” or the “Firm”) has reached a definitive settlement to promote its Masterflex enterprise unit to Avantor for $2.9 billion in an all-cash transaction.
In executing its Leaders Technique™, GTCR acquired Antylia in partnership with CEO Bernd Brust in 2019. Since then, the Firm has made important investments in its merchandise and business infrastructure and accomplished two strategic add-on acquisitions in its Life Sciences enterprise unit to develop its product portfolio, scale and geographic footprint. The Firm, rebranded as Antylia Scientific in 2021 to replicate its evolution right into a diversified life sciences instruments firm, is organized into two distinct enterprise models: Masterflex and Life Sciences.
Masterflex is a market chief in peristaltic and single-use bioprocessing options together with its Masterflex and Ismatec vary of peristaltic pumps, tubing, circulate meters and single-use parts and assemblies. The Masterflex product portfolio is utilized by pharma and biotech prospects for analysis and manufacturing of biologic medicine, vaccines and cell & gene therapies.
Following the sale of the Masterflex enterprise unit, GTCR and different shareholders will proceed to personal Antylia and its remaining property, which embody its portfolio of life sciences merchandise. Mr. Brust and the Antylia senior administration crew will proceed to steer the Firm.
Antylia Chairman and CEO, Bernd Brust, stated, “As part of Antylia Scientific, the Masterflex Bioprocessing enterprise has achieved distinctive outcomes by means of important product, functionality and buyer enlargement. In its subsequent stage of development, Masterflex can be tremendously complemented by Avantor’s current capabilities.”
Dean Mihas, Managing Director and Co-CEO of GTCR, added: “Bernd and the Antylia crew have achieved a superb job remodeling Masterflex right into a high-growth bioprocessing asset, supporting the event and manufacturing of biologic medicine and vaccines. We sit up for the way forward for Masterflex inside Avantor and our subsequent chapter of continuous to construct Antylia Scientific.”
Sean Cunningham, a Managing Director of GTCR, added: “This represents one other wonderful instance of our Leaders Technique™ strategy. Our partnership with Bernd and crew enabled us to develop Antylia, together with investing within the Masterflex business group and bioprocessing merchandise in addition to the remaining life sciences portfolio. We’re excited to help the continued development of the group going ahead.”
The transaction is anticipated to shut within the fourth quarter of 2021, topic to regulatory approvals and satisfaction of customary closing circumstances. J.P. Morgan Securities LLC and Perella Weinberg Companions LP served as monetary advisors for Antylia Scientific. Kirkland & Ellis LLP offered authorized counsel.
Based in 1980, GTCR is a number one personal fairness agency targeted on investing in development firms within the Healthcare, Monetary Providers & Expertise, Expertise, Media & Telecommunications, and Development Enterprise Providers industries. The Chicago-based agency pioneered The Leaders Technique™ – discovering and partnering with administration leaders in core domains to determine, purchase and construct market-leading firms by means of transformational acquisitions and natural development. Since its inception, GTCR has invested greater than $20 billion in over 250 firms. For extra data, please go to www.gtcr.com.
About Antylia Scientific
Antylia Scientific™ is a diversified life science instruments enterprise with a portfolio of merchandise serving the pharma, biopharma, healthcare and environmental markets. Our life sciences portfolio contains well-recognized manufacturers such because the environmental sampling and testing innovator, Environmental Specific®; real-time monitoring and chilly storage experience at Traceable®; our requirements and exterior diagnostic management specialists, SPEX® and ZeptoMetrix®; and our lab necessities and consumables Cole-Parmer Necessities® model. For extra data, please go to www.antylia.com.